Avanir's experimental drug Zenvia appears safe and effective for involuntary emotional expression in ALS

posted on August 16, 2009 - 9:00pm
The pharamaceutical company Avanir has announced positive results for its phase 3 trial to treat unwanted episodes of laughing and crying in patients with ALS and multiple sclerosis using its experimental drug Zenvia.

New content is being added every day. Please check back again.